Media Coverage

Immunotherapy Integrated Research Center (IIRC)

Media Coverage

Featured Coverage

Dr. Brian Till

Dr. Brian Till

Photo by Robert Hood / Fred Hutch News Service

Tinkering with T Cells
CancerToday | Fall 2017

Dr. Brian Till gave context to CAR-T therapies for blood cancers in an article summarizing recent FDA approvals of the therapy which appeared in a magazine published by the world's oldest and largest professional organization of its kind, the American Association for Cancer Research.


Read more

Tinkering with T cells
Cancer Today, Sept. 25, 2017
Dr. Brian Till gave context to CAR-T therapies for blood cancers in an article summarizing recent FDA approvals of the therapy which appeared in a magazine published by the world's oldest and largest professional organization of its kind, the American Association for Cancer Research.

Juno Therapeutics ready for another round in war on cancer
The Seattle Times, Sept. 15, 2017
Dr. Stanley Riddell commented on advances in CAR-T therapy for treating blood cancers and how he believes that the side effects of the therapy will be manageable. Juno is a spinout of Fred Hutch.

US clears breakthrough gene therapy for childhood leukemia
Associated Press, Aug. 31, 2017
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia

US clears breakthrough gene therapy for childhood leukemia
ABC News, Aug. 31, 2017
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia

FDA approves breakthrough ‘living drug’ for childhood leukemia with $475,000 price tag
The Seattle Times, Aug. 30, 2017
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia

First cancer 'living drug' gets go-ahead
BBC News, Aug. 30, 2017
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CART cells to fight childhood leukemia

Hailing a breakthrough in fighting cancer, FDA approves gene therapy that functions as a ‘living drug’
The Los Angeles Times, Aug. 30, 2017
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CART cells to fight childhood leukemia

Landmark FDA approval clears the way for gene therapy treatments that fight cancer
GeekWire, Aug. 30, 2017
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CART cells to fight childhood leukemia

Novartis goes first
GeonomeWeb, Aug. 30, 2017
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CART cells to fight childhood leukemia

Novartis wins historic FDA nod, prices car-t for leukemia at $475,00
Xconomy, Aug. 30, 2017
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR-T cells to fight childhood leukemia

Pioneering cancer gene therapy gets green light — and $475,000 price tag
Kaiser Health News , Aug. 30, 2017
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia

FDA approves the first immunotherapy drug for childhood leukemia
KING-TV, Aug. 30, 2017
Dr. Damian Green was quoted on the FDA’s announcement and its significance. In addition, the story featured footage of Dr. Jerry Radich in the lab.

Mining the 'gold rush' of immunotherapy clinical trials
ASH Clinical News, Oct. 1, 2017
Dr. Cameron Turtle discussed some of the challenges in developing immunotherapy treatments, such as CAR T.

These experimental treatments target brain cancer like John McCain’s
The Washington Post, July 26, 2017
Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Sen. John McCain was diagnosed with, is particularly complicated

Brain cancer like McCain's has hundreds of experimental therapies (with little success)
Forbes, July 24, 2017
Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Senator John McCain was diagnosed with, is particularly complicated

Why John McCain's type of brain tumor is so hard to treat
Forbes, July 21, 2017
Dr. Eric Holland was quoted in an article on glioblastoma, the type of brain cancer Sen. John McCain was diagnosed

The future of treatment for glioblastoma
CNN, July 20, 2017
Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Senator John McCain was diagnosed with, is particularly complicated

Novel cancer treatment wins endorsement of FDA advisers
The Washington Post, July 17, 2017
Dr. David Maloney quoted in an article on the Food and Drug Administration recommendation to approve a CAR-T therapy

First gene therapy — ‘a true living drug’ — on the cusp of FDA approval
The Washington Post, July 11, 2017
Dr. David Maloney quoted in an article on the Food and Drug Administration recommendation to approve a CAR-T therapy

Doctors reprogram patients own cells into cancer assasins
Associated Press, June 12, 2017
Story explores the field of cellular immunotherapy to treat cancer, featuring leading Fred Hutch researchers Drs. Phil Greenberg, Stan Riddell and David Maloney

Doctors reprogram patients' own cells into cancer assassins
The Houston Chronicle [via Associated Press], June 12, 2017
Story explores the field of cellular immunotherapy to treat cancer, featuring leading Fred Hutch researchers Drs. Phil Greenberg, Stan Riddell and David Maloney

Hope and hype around cancer immunotherapy
CNN, June 2, 2017
Article explores the current state of cancer immunotherapy research, quoting Dr. Phil Greenberg, as the American Society for Clinical Oncology annual meeting begins

Q&A: Some preclinical promise in using cellular therapy for ovarian cancer
STAT, Apr. 4, 2017
Dr. Kristin Anderson discusses promising findings from an immunotherapy study she presented at the annual American Association for Cancer Research meeting

Fred Hutch study: Cancer drug inspired by bacteria could boost immunotherapy treatments
GeekWire, Apr. 3, 2017
Article covers Dr. Seth Pollack's presentation at the American Association for Cancer Research's annual conference. Pollack's study in patients with sarcoma found a bacteria-inspired drug could help heighten immune response

Novel 'barcode' tracking of T-cells in immunotherapy patients identifies likely cancer
R&D Magazine, Mar. 1, 2017
Follows a study by Dr. Aude Chapuis and collaborators using a technique akin to barcoding to identify which T cells deliver the largest anti-cancer punch

Researchers find way to pinpoint best cancer-fighting T-cells
Immuno-Oncology News, Mar. 7, 2017
Follows a study by Dr. Aude Chapuis and collaborators using a technique akin to barcoding to identify which T cells deliver the largest anti-cancer punch

Novel 'barcode' tracking of T-cells in immunotherapy patients identifies likely cancer
R&D Magazine, Mar. 1, 2017
Follows a study by Dr. Aude Chapuis and collaborators using a technique akin to barcoding to identify which T cells deliver the largest anti-cancer punch

Fred Hutch researcher aims to cure HIV with 'ninja warrior' cells
Puget Sound Business Journal, Feb. 28, 2017
Profile of Dr. Larry Corey and his research on how immunotherapy could be used to attack HIV and other viruses

Cancer: New way of tracking rare T cells should improve immunotherapy
Medical News Today, Feb. 27, 2017
Follows a study by Dr. Aude Chapuis and collaborators using a technique akin to barcoding to identify which T cells deliver the largest anti-cancer punch

Could immunotherapy cure HIV? $2.6M grant will help Fred Hutch researcher find out
GeekWire, Jan. 20, 2017
Article about a $2.6 million grant from Gilead Sciences to Dr. Larry Corey for HIV-cure research

Efforts continue to expand immunotherapy impact in sarcoma
OncLive, Jan. 12, 2017
Q&A with Dr. Elizabeth Loggers about new findings in mmunotherapy for sarcoma

Fred Hutchinson Cancer Research Center opens immunotherapy clinic
HemOnc Today, Jan. 4, 2017
Interview with newly-opened Bezos Family Immunotherapy Clinic medical director Dr. David Maloney

Immunotherapy: Leukaemia clinical trial sees 93% remission rate in advanced cancer patients
International Business Times, April 26, 2016
Quotes Dr. David Maloney about "extraordinary" response rates from an early-phase clinical trial testing a form of immunotherapy against advanced leukemia

New twist on T-cell therapy puts leukemia patients in remission
The Seattle Times, April 25, 2016
Quotes Hutch immunotherapy researcher Dr. David Maloney about promising new clinical trial results published today reporting 27 out of 29 leukemia patients having no detectable signs of disease

Immunotherapy, global health & more at Seattle's Life Sci Disruptors
Xconomy, April 22, 2016
Article promoting Xconomy's annual life sciences forum, "Seattle's Life Science Disruptors 2016," which will be held May 2 at Fred Hutch. Presenters will include Dr. Cameron Turtle, an immunotherapy researcher at the Hutch, who will talk about a patient whose desperate situation was turned into a "a new lease on life."

T-cells can be engineered to better attack mesothelioma and other cancers, researcher tells AACR
Mesothelioma Research News, April 22, 2016
Coverage of an immunotherapy presentation by Dr. Phil Greenberg last week at the annual meeting of the American Association for Cancer Research

Fighting cancer with killer T-cells: 5 developments to watch
Forbes, April 21, 2016
Article about advances in immunotherapy mentions the research of Fred Hutch's Dr. Phil Greenberg as well as spinoff biotech company Juno Therapeutics

Cancer: The final frontier
The Atlantic, April 21, 2016
Article about the cancer moonshot and immunotherapy mentions Drs. Paul Nghiem and Shailender Bhatia, who are part of the Cancer Immunotherapy Trials Network, which is based at Fred Hutch

Keytruda active in Merkel cell cancer
MedPage Today, April 20, 2016
Coverage of research by Dr. Paul Nghiem

Merkel cell carcinoma patients who received pembrolizumab often had durable responses
Medical News Today, April 20, 2016
Coverage of new study by Dr. Paul Ngheim, presented at the annual meeting of the American Association for Cancer Research in New Orleans

Pembrolizumab yields lasting Merkel cell carcinoma responses
Cancer Discovery, April 20, 2016
Coverage of a study by Dr. Paul Nghiem presented in New Orleans this week

Indian-American scientist engineers T-cells to treat pancreatic cancer
Indo-Asian News Service (from The New Indian Express), April 19, 2016
Coverage of findings by Dr. Sunil Hingorani presented at the American Association for Cancer Research Annual Meeting in New Orleans

Merck's Keytruda shows promise for Merkel cell carcinoma
Drug Discovery & Development, April 19, 2016
Coverage of new study by Dr. Paul Ngheim, a clinical researcher at Fred Hutch and the University of Washington

The list of cancers being taken down by immunotherapy keeps growing
The Washington Post, April 19, 2016
Coverage of Merkel cell carcinoma immunotherapy research presented today by Dr. Paul Nghiem at the annual meeting of the American Association for Cancer Research in New Orleans also includes an interview with one of his patients, Stan Collender

Checkpoint inhibitor shows promise in MCC
Dermwire, April 19, 2016
Coverage of new findings regarding the use of immunotherapy to treat advanced Merkel cell carcinoma presented by Dr. Paul Ngheim at the AACR annual meeting

She wouldn't be denied
Associated Press (from The Washington Times), April 16, 2016
Profile of Fred Hutch immunotherapy patient Stephanie Florence

Cocktails for cancer with a measure of immunotherapy
Nature, April 13, 2016
Article about the next frontier in cancer immunotherapy quotes Dr. Martin "Mac" Chever, a cancer immunologist at Fred Hutch

Guidelines highlight revolution in advanced melanoma therapies
Dermatology News, April 8, 2016
Coverage of a recent presentation by Fred Hutch melanoma researcher Dr. John Thompson at the National Comprehensive Cancer Network annual conference

Cancer moonshot meeting: Q&A with nurse on panel with VP Joe Biden
ADVANCE for Nurses, April 7, 2016
Publication of a Fred Hutch News Service Q&A with Dr. Angelique Richard, chief nurse executive and vice president of clinical operations at Seattle Cancer Care Alliance, who participated in a panel discussion with Vice President Joe Biden during his March 21 visit to Fred Hutch

Biden's 'cancer moonshot' leaning on public-private funding for liftoff
Washington Examiner, April 4, 2016
Mentions Vice President Joe Biden's recent visit to Fred Hutch

What if your immune system could be taught to kill cancer?
TIME, April 4, 2016
Cover story features the lifesaving immunotherapy research of Fred Hutch's Drs. David Maloney, Cameron Turtle and Stan Riddell, among others, and profiles immunotherapy patient Stephanie Florence, whose lymphoma was put into long-term remission

Driving cancer immunotherapy
Genetic Engineering & Biotechnology News, April 1, 2016
Quotes Dr. Harlan Robins of the Public Health Sciences Division about using high-throughput sequencing to amplify T-cell receptors used in cancer immunotherapy

Biden visits Seattle to move cancer research forward
KUOW-FM, March 22, 2016

Biden tours Seattle cancer center, sees more cooperation
Associated Press (from MyNorthwest.com), March 21, 2016

Joe Biden speaks at Seattle’s Fred Hutch Research Center
KIRO-TV, March 21, 2016

Lori Matsukawa interview with Vice Pres. Biden
KING-TV, March 21, 2016
News anchor Lori Matsukawa interviews Vice President Joe Biden during his "moonshot" listening tour at Fred Hutch

Biden tours Seattle cancer center, stops for pizza
KOMONews.com, March 21, 2016

Biden talks cancer ‘Moonshot’ and research cooperation at Fred Hutch in Seattle
KPLU-FM, March 21, 2016

VP Joe Biden: Sharing big data is vital to cancer research and Seattle can help
Puget Sound Business Journal, March 21, 2016

Joe Biden says Americans need more optimism for the future: ‘We’ve lost some of our mojo’
GeekWire, March 21, 2016

Fred Hutchinson Cancer Research Center is the launchpad of new cures
The Seattle Times, March 21, 2016
Op-ed by Dr. Gary Gilliland, president and director of Fred Hutch

Back to Top